Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 26.41B | 27.01B | 29.19B | 26.83B | 23.14B |
Gross Profit | 11.68B | 11.50B | 11.61B | 11.54B | 9.69B |
EBITDA | 6.83B | 6.82B | 6.10B | 6.42B | 5.72B |
Net Income | 2.93B | 3.06B | 3.31B | 2.30B | 1.70B |
Balance Sheet | |||||
Total Assets | 54.28B | 52.69B | 57.60B | 59.88B | 53.22B |
Cash, Cash Equivalents and Short-Term Investments | 5.35B | 6.09B | 9.83B | 6.69B | 5.19B |
Total Debt | 12.92B | 13.12B | 14.91B | 16.61B | 13.76B |
Total Liabilities | 26.33B | 25.90B | 27.99B | 29.41B | 24.60B |
Stockholders Equity | 27.24B | 26.00B | 28.67B | 27.68B | 26.07B |
Cash Flow | |||||
Free Cash Flow | 4.02B | 3.96B | 3.01B | 3.51B | 3.50B |
Operating Cash Flow | 5.67B | 5.47B | 4.56B | 5.04B | 4.62B |
Investing Cash Flow | -2.04B | -3.47B | 2.08B | -4.71B | -1.23B |
Financing Cash Flow | -4.37B | -5.22B | -3.25B | 1.11B | -1.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | £64.38B | 20.15 | 15.72% | 1.51% | 2.11% | 3.37% | |
78 Outperform | $43.44B | 2.49 | 12.65% | 2.61% | -18.01% | ― | |
78 Outperform | $36.33B | 38.43 | 11.89% | 0.69% | 0.19% | 4.33% | |
75 Outperform | $12.70B | 8.18 | 7.12% | 1.00% | -9.62% | 795.20% | |
69 Neutral | $34.84B | 33.23 | 11.88% | 0.55% | -0.54% | -48.61% | |
61 Neutral | $9.46B | 8.05 | -0.54% | 3.14% | 2.52% | -54.55% |